Kiromic BioPharma Management
Management criteria checks 0/4
Kiromic BioPharma's CEO is Pietro Bersani, appointed in Jan 2022, has a tenure of 1.42 years. total yearly compensation is $697.49K, comprised of 71.2% salary and 28.8% bonuses, including company stock and options. directly owns 2.19% of the company’s shares, worth €60.70K. The average tenure of the management team and the board of directors is 0.9 years and 2.7 years respectively.
Key information
Pietro Bersani
Chief executive officer
US$697.5k
Total compensation
CEO salary percentage | 71.2% |
CEO tenure | 1.4yrs |
CEO ownership | 2.2% |
Management average tenure | less than a year |
Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2023 | n/a | n/a | -US$33m |
Dec 31 2022 | US$697k | US$497k | -US$35m |
Sep 30 2022 | n/a | n/a | -US$39m |
Jun 30 2022 | n/a | n/a | -US$33m |
Mar 31 2022 | n/a | n/a | -US$29m |
Dec 31 2021 | US$336k | US$168k | -US$26m |
Sep 30 2021 | n/a | n/a | -US$19m |
Jun 30 2021 | n/a | n/a | -US$15m |
Mar 31 2021 | n/a | n/a | -US$22m |
Dec 31 2020 | US$63k | n/a | -US$20m |
Compensation vs Market: Pietro's total compensation ($USD697.49K) is above average for companies of similar size in the German market ($USD418.12K).
Compensation vs Earnings: Pietro's compensation has increased whilst the company is unprofitable.
CEO
Pietro Bersani (55 yo)
1.4yrs
Tenure
US$697,486
Compensation
Mr. Pietro Bersani, CPA, J.D., serves as Chief Executive Officer at Kiromic BioPharma, Inc. since May 10, 2022 and serves as Director since January 27, 2022. He serves as Principal Financial Officer at Kir...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, Principal Financial Officer & Director | 1.4yrs | US$697.49k | 2.19% $ 60.7k | |
Chief Financial Officer | less than a year | no data | no data | |
CSO & Interim COO | less than a year | no data | 0.013% $ 373.5 | |
Chief of Staff | 3.7yrs | US$442.12k | 0% $ 0 | |
Controller | less than a year | no data | no data |
0.9yrs
Average Tenure
Experienced Management: 5JU0's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, Principal Financial Officer & Director | 3yrs | US$697.49k | 2.19% $ 60.7k | |
Independent Chairperson of the Board | 2.7yrs | US$214.20k | 0.64% $ 17.8k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 3.3yrs | US$187.96k | 0.64% $ 17.8k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 2.4yrs | no data | no data | |
Member of Scientific Advisory Board | 1.8yrs | no data | no data |
2.7yrs
Average Tenure
56yo
Average Age
Experienced Board: 5JU0's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.